Suppr超能文献

使用多模态成像对儿童局限性硬皮病(硬斑病)对类固醇和甲氨蝶呤的治疗反应及疾病可逆性进行前瞻性评估。

Prospective evaluation of treatment response and disease reversibility of paediatric localized scleroderma (morphoea) to steroids and methotrexate using multi-modal imaging.

作者信息

Weibel L, Theiler M, Howell K J, Denton C P, Waelchli R, Atherton D, Woo P, Harper J I

机构信息

Department of Dermatology, Pediatric Skin Center, University Children's Hospital Zurich, Zurich, Switzerland.

Microvascular Diagnostics, Royal Free Hospital, Institute of Immunity and Transplantation, London, UK.

出版信息

J Eur Acad Dermatol Venereol. 2020 Jul;34(7):1609-1616. doi: 10.1111/jdv.16308. Epub 2020 Mar 27.

Abstract

BACKGROUND

Paediatric localized scleroderma is a severe inflammatory disorder associated with tissue atrophy, often leading to disability. Assessing disease activity and response to treatment has always been challenging and remains an important difficulty in clinical practice.

OBJECTIVES

To investigate prospectively the efficacy of systemic treatment with corticosteroids and methotrexate in children with localized scleroderma and the validity of infrared thermography, laser Doppler flowmetry and high-frequency ultrasound in assessing disease activity.

METHODS

Children with localized scleroderma were prospectively treated with corticosteroids (initially pulsed IV methylprednisolone 30 mg/kg/day, maximum 500 mg/day and/or oral prednisolone 0.5-1 mg/kg/day) and methotrexate (15 mg/m weekly). Treatment response was evaluated using a clinical activity score. Skin temperature, blood flow, dermal thickness and dermal echogenicity of clinically active skin lesions were determined in relation to the unaffected contralateral site at baseline and after 3, 6, 12 and 18 months. Patient charts were later reviewed for long-term follow-up.

RESULTS

Twenty-two patients were included [age 6.0 (0.2-14.4] years; female-to-male ratio 3.4 : 1) All responded well to therapy. Disease reversibility was demonstrated in the majority of children with partial resolution of skin sclerosis and regrowth of hair. Laser Doppler flowmetry and high-frequency ultrasound findings correlated with disease activity at baseline. Thermography had no added value in this cohort. The recurrence rate was 36% in the follow-up period.

CONCLUSIONS

Corticosteroids and methotrexate are highly effective as first-line therapy in paediatric localized scleroderma, leading to partial reversal of skin manifestations. However, the recurrence rate is substantial and affected children require long-term follow-up. Laser Doppler flowmetry and high-frequency ultrasound correlate with disease activity in the acute phase and may assist decision-making in these patients.

摘要

背景

儿童局限性硬皮病是一种与组织萎缩相关的严重炎症性疾病,常导致残疾。评估疾病活动度和治疗反应一直具有挑战性,仍是临床实践中的一个重要难题。

目的

前瞻性研究皮质类固醇和甲氨蝶呤全身治疗儿童局限性硬皮病的疗效,以及红外热成像、激光多普勒血流仪和高频超声在评估疾病活动度方面的有效性。

方法

对局限性硬皮病患儿进行前瞻性治疗,使用皮质类固醇(初始静脉注射甲泼尼龙脉冲剂量30mg/kg/天,最大剂量500mg/天和/或口服泼尼松龙0.5 - 1mg/kg/天)和甲氨蝶呤(15mg/m²每周)。使用临床活动评分评估治疗反应。在基线以及3、6、12和18个月后,测定临床活动皮肤病变相对于未受影响的对侧部位的皮肤温度、血流、真皮厚度和真皮回声。随后查阅患者病历进行长期随访。

结果

纳入22例患者[年龄6.0(0.2 - 14.4)岁;男女比例3.4∶1]。所有患者对治疗反应良好。大多数患儿出现疾病可逆性,皮肤硬化部分消退且毛发再生。激光多普勒血流仪和高频超声检查结果与基线时的疾病活动度相关。热成像在该队列中无附加价值。随访期复发率为36%。

结论

皮质类固醇和甲氨蝶呤作为儿童局限性硬皮病的一线治疗非常有效,可使皮肤表现部分逆转。然而,复发率较高,患病儿童需要长期随访。激光多普勒血流仪和高频超声与急性期疾病活动度相关,可能有助于这些患者的决策制定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验